(Q42537934)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

review article

1 reference

title

Serotonergic basis of antipsychotic drug effects in schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

author name string

J A Lieberman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

G Duncan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

L Sikich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

M Chakos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

D E Nichols

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

J E Kraus

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

language of work or name

English

0 references

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

1099-1117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Hallucinogenic phenylethylamines: interactions with serotonin turnover and receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of D-amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Association between clozapine response and allelic variation in 5-HT2A receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Cytochrome P4502D6 genotype does not determine response to clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

5-HT3-like receptors in the rat medial prefrontal cortex: an electrophysiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The induction of serotonin3-like receptor supersensitivity and dopamine receptor subsensitivity in the rat medial prefrontal cortex after the intraventricular administration of the neurotoxin 5,7-dihydroxytryptamine: a microiontophoretic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

5-HT1A agonist and dexamethasone reversal of para-chloroamphetamine induced loss of MAP-2 and synaptophysin immunoreactivity in adult rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Modulation of in vivo neuronal sprouting by serotonin in the adult CNS of the snail

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

5-HT3 receptor-active drugs alter development of spinal serotonergic innervation: lack of effect of other serotonergic agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Neurotransmitter Receptors in Frontal Cortex of Schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Fenfluramine depletes serotonin from the developing cortex and alters thalamocortical organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Evidence for involvement of 5-hydroxytryptamine in the actions of amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Clozapine attenuates meta-chlorophenylpiperazine (mCPP)-induced plasma cortisol increases in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonin potentiates dopamine inhibition of ventral tegmental area neurons in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

A subset of ventral tegmental area neurons is inhibited by dopamine, 5-hydroxytryptamine and opioids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Antipsychotic drugs and catecholamine synapses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Fluoxetine reduces intravenous cocaine self-administration in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Role of 5-hydroxytryptamine in mental diseases and its antagonism to lysergic acid derivatives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Effect of serotonin antagonism in schizophrenia: a pilot study with setoperone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Regional differences of serotonin-mediated synaptic plasticity in the chicken spinal cord with development and aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The effects of serotonin on the morpho-functional development of rat cerebral neocortex in tissue culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The dopamine receptor: Differential binding of d-LSD and related agents to agonist and antagonist states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Dopamine in schizophrenia: a review and reconceptualization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: a comparison between the effects of 5-hydroxytryptamine, acetylcholine, and glutamate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Prenatal exposure of rats to antidepressant drugs down-regulates beta-adrenoceptors and 5-HT2 receptors in cerebral cortex. Lack of correlation between 5-HT2 receptors and serotonin-mediated behaviour.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Functional promoter polymorphism of the human serotonin transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Ontogenetic development of 5-HT1D receptors in human brain: an autoradiographic study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Evidence for the existence of a raphe projection to the substantia nigra in rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The dorsal and medial raphe projections to the substantia nigra in the rat: electrophysiological, biochemical and behavioural observations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonin 5-HT3 and 5-HT4 receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Assignment of the 5HT7 receptor gene (HTR7) to chromosome 10q and exclusion of genetic linkage with tourette syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Effects of 5-HT3 receptor-selective agents on locomotor activity in rats following injection into the nucleus accumbens and the ventral tegmental area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Structure-activity studies on amphetamine analogs using drug discrimination methodology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Novel effects of serotonin on neurite outgrowth in neurons cultured from embryos of Helisoma trivolvis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Noradrenergic Overactivity in Chronic Schizophrenia: Evidence Based on Cerebrospinal Fluid Noradrenaline and Cyclic Nucleotide Concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonin as a stimulator of hippocampal cell differentiation in tissue culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Administration of tryptophan-enriched diets to pregnant rats retards the development of the serotonergic system in their offspring.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Functional correlates of serotonin 5-HT1 recognition sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The serotonin receptor subtype 2 locus HTR2 is on human chromosome 13 near genes for esterase D and retinoblastoma-1 and on mouse chromosome 14.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The organization of divergent axonal projections from the midbrain raphe nuclei in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The MCPP challenge test in schizophrenia: hormonal and behavioral responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Brain ventricular size and CSF monoamine metabolites in an adolescent inpatient population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

m-Chlorophenylpiperazine as a probe of serotonin function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Site-directed mutagenesis of a single residue changes the binding properties of the serotonin 5-HT2 receptor from a human to a rat pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

5-HT2 antagonism and EPS benefits: is there a causal connection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonin-dopamine interaction and its relevance to schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

7 January 2021

SSCP at the HTR1DA locus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

In vivo properties of SB 200646A, a 5-HT2C/2B receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

A Sac I RFLP is detected with the 5-HT1a serotonin receptor probe G21.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Cloning, characterization, and chromosomal localization of a human 5-HT6 serotonin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The behavioral effect of m-chlorophenylpiperazine (mCPP) and methylphenidate in first-episode schizophrenia and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The serotoninergic innervation of cerebral cortex: different classes of axon terminals arise from dorsal and median raphe nuclei.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Mapping of the serotonin 5-HT1D beta autoreceptor gene on chromosome 6 and direct analysis for sequence variants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The effects of putative 5-hydroxytryptamine receptor active agents on D-amphetamine self-administration in controls and rats with 5,7-dihydroxytryptamine median forebrain bundle lesions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Some effects of the hallucinogenic drug 2, 5-dimethoxy-4-methyl amphetamine on the metabolism of biogenic amines in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Correlates of lateral ventricular size in chronic schizophrenia, II: biological measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonergic inhibition of catecholamine-induced behavioral arousal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Complex stimulus properties of LSD: a drug discrimination study with alpha 2-adrenoceptor agonists and antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Genetic variation of 5-HT2A receptor and response to clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Hallucinogenic drugs are partial agonists of the human platelet shape change response: a physiological model of the 5-HT2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Autoradiography of LSD and 2,5-dimethoxyphenylisopropylamine psychotomimetics demonstrates regional, specific cross-displacement in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Characterization and radioautography of [3H]LSD binding by rat brain slices in vitro: the effect of 5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonergic lesions alter cocaine-induced locomotor behavior and stress-activation of the mesocorticolimbic dopamine system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

[(3)H]lysergic acid diethylamide (LSD): differential agonist and antagonist binding properties at 5-HT receptor subtypes in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Neuropsychological correlates of syndromes in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Identification of genetic variation in the human serotonin 1D beta receptor gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

A PET study of 5-HT2 and D2 dopamine receptor occupancy induced by olanzapine in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Laminar development of the mouse barrel cortex: effects of neurotoxins against monoamines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Neurotransmitter receptors in brain in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Mapping of the serotonin 5-HT1D alpha autoreceptor gene (HTR1D) on chromosome 1 using a silent polymorphism in the coding region.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Perfusate serotonin increases extracellular dopamine in the nucleus accumbens as measured by in vivo microdialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Suicide and aggression in schizophrenia. Neurobiologic correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Effect of N,N-Dimethyltryptamine and D-Lysergic Acid Diethylamide on the Release of 5-Hydroxyindoles in Rat Forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Special antagonism of amphetamine-induced abnormal behaviour. Inhibition of stereotyped activity with increase of some normal activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Effects of 5-HT on thalamocortical synaptic transmission in the developing rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Neurotrophic effects of ipsapirone and other 5-HT1A receptor agonists on septal cholinergic neurons in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Fluoxetine pretreatment reduces breaking points on a progressive ratio schedule reinforced by intravenous cocaine self-administration in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Response of central monoaminergic neurons to lisuride: Comparison with LSD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonin regulates gap junction coupling in the developing rat somatosensory cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Fenfluramine-induced activation of the immediate-early gene c-fos in the striatum: possible interaction between serotonin and dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Choroid plexus epithelial cells in primary culture: a model of 5HT1C receptor activation by hallucinogenic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

The role of 5-HT2A receptors in antipsychotic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Antipsychotic drug doses and neuroleptic/dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Systematic screening for mutations in the human serotonin 1F receptor gene in patients with bipolar affective disorder and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Fenfluramine and chronic schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

New Polymorphism for the Human Serotonin 1D Receptor Variant (5-HT 1Dβ ) not Linked to Schizophrenia in Five Canadian Pedigrees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Cortical-striatal-thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonergic modulation of dopamine measured with [11C]raclopride and PET in normal human subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Direct Immunohistochemical Evidence of the Existence of 5-HT1A Autoreceptors on Serotoninergic Neurons in the Midbrain Raphe Nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Pilot study on the effects of fenfluramine on negative symptoms in twelve schizophrenic inpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonin content of some mammalian tissues and urine and a method for its determination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Synaptic structure and connectivity of serotonin terminals in the ventral tegmental area: potential sites for modulation of mesolimbic dopamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: a fluorescent retrograde double labeling study in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Development of the serotonergic system in the rat embryo: an immunocytochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Modulation of the A10 dopamine system: electrophysiological studies of the role of 5-HT3-like receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Tritiated LSD Binding in Frontal Cortex in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Localization of 5-HT1A receptors to astroglial cells in adult rats: implications for neuronal-glial interactions and psychoactive drug mechanism of action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Voltage- and ligand-activated inwardly rectifying currents in dorsal raphe neurons in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Monoamines and monoamine metabolites in brains from demented schizophrenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

Serotonergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900187-5

10.1016/S0006-3223(98)00187-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9836014%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference